A critical review on Chagas disease chemotherapy

JR Coura, SL De Castro - Memórias do Instituto Oswaldo Cruz, 2002 - SciELO Brasil
In this" Critical Review" we made a historical introduction of drugs assayed against Chagas
disease beginning in 1912 with the works of Mayer and Rocha Lima up to the experimental …

Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease

FS Machado, WO Dutra, L Esper, KJ Gollob… - Seminars in …, 2012 - Springer
Chagas disease caused by Trypanosoma cruzi remains an important neglected tropical
disease and a cause of significant morbidity and mortality. No longer confined to endemic …

Immnunological Control of Trypanosoma cruzi Infection and Pathogenesis of Chagas' Disease

Z Brener, RT Gazzinelli - International archives of allergy and …, 1997 - karger.com
The major goal of studies on immunity to Trypanosoma cruzi is the understanding of
immunological mechanisms involved in resistance to this protozoan as well as the …

Cell biology of Trypanosoma cruzi

W De Souza - International review of cytology, 1984 - Elsevier
Publisher Summary Among the protozoa of the Trypanosomatidae family, a large number of
species represent agents of diseases, such as Chagas' disease. This chapter reviews some …

[HTML][HTML] Chagas disease: What is known and what should be improved: a systemic review

JR Coura, J Borges-Pereira - Revista da Sociedade Brasileira de …, 2012 - SciELO Brasil
This study consists of a broad review on what is known and what should be improved
regarding knowledge of Chagas disease, not only through analysis on the main studies …

Chagas disease diagnostic applications: present knowledge and future steps

V Balouz, F Agüero, CA Buscaglia - Advances in parasitology, 2017 - Elsevier
Chagas disease, caused by the protozoan Trypanosoma cruzi, is a lifelong and debilitating
illness of major significance throughout Latin America and an emergent threat to global …

Lytic anti-α-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored …

IC Almeida, MA Ferguson, S Schenkman… - Biochemical …, 1994 - portlandpress.com
Sera of patients with chronic Chagas' disease (American trypanosomiasis) contain elevated
levels of anti-alpha-galactosyl antibodies that are lytic to Trypanosoma cruzi. The T. cruzi …

WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production

S Hamano, K Himeno, Y Miyazaki, K Ishii, A Yamanaka… - Immunity, 2003 - cell.com
WSX-1 is a class I cytokine receptor with homology to the IL-12 receptors and is essential for
resistance to Leishmania major infection. In the present study, we demonstrated that WSX-1 …

IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection

Y Miyazaki, S Hamano, S Wang… - The Journal of …, 2010 - journals.aai.org
IL-17A is a key cytokine that induces inflammatory responses through the organized
production of inflammatory cytokines, such as IL-6, TNF-α, and GM-CSF, and induces …

Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies?

YM Gomes, V Lorena, AO Luquetti - Memórias do Instituto Oswaldo …, 2009 - SciELO Brasil
In the acute phase and in the chronic forms of Chagas disease, the etiological diagnosis
may be performed by detection of the parasite using direct or indirect parasitological …